Skip Navigation U.S. Department of Health and Human Services www.hhs.gov
Agency for Healthcare Research Quality www.ahrq.gov
Archive print banner
Data Sources for the At-Risk Community-Dwelling Patient Population

This resource was developed by AHRQ as part of its Public Health Emergency Preparedness program, which was discontinued on June 30, 2011. Many of AHRQ's PHEP materials and activities will be supported by other Federal agencies. Notice of transfer to another agency will be posted on this site.

This information is for reference purposes only. It was current when produced and may now be outdated. Archive material is no longer maintained, and some links may not work. Persons with disabilities having difficulty accessing this information should contact us at: https://info.ahrq.gov. Let us know the nature of the problem, the Web address of what you want, and your contact information.

Please go to www.ahrq.gov for current information.

Table 11. Data Availability for Schedule II Controlled Substances

Data Availability

Schedule II Controlled Substances Data

Advantage

Disadvantage

Public use files

SAMHDA

  • Counts patients receiving methadone or buprenorphine as inpatients, outpatients, and residential.
  • Data from 2005.
  • County-level data.

CMS approval/
DUA required

Medicare claims

  • Captures the use of Schedule II controlled substances by persons living in the Worcester zip code.
  • Data are limited to a segment of the population that is older than 65, has a disability, or has ESRD.

Medicaid claims

  • Captures the use of Schedule II controlled substances by persons living in the Worcester zip code.
  • Data are limited to low-income individuals, which varies from State to State and year to year.

Return to Document

The information on this page is archived and provided for reference purposes only.

 

AHRQ Advancing Excellence in Health Care